Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups

Micro-Abstract We aimed to estimate the usefulness of scoring categories of IHC Ki67 as a prognostic factor for breast cancer subgroups. Our data demonstrated that Ki67 scores have a prognostic value in breast cancer patients with ER-positive and HER2-negative tumors.

Saved in:
Bibliographic Details
Published inClinical breast cancer Vol. 14; no. 5; pp. 323 - 329.e3
Main Authors Niikura, Naoki, Masuda, Shinobu, Kumaki, Nobue, Xiaoyan, Tang, Terada, Mizuho, Terao, Mayako, Iwamoto, Takayuki, Oshitanai, Risa, Morioka, Toru, Tuda, Banri, Okamura, Takuho, Saito, Yuki, Suzuki, Yasuhiro, Tokuda, Yutaka
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2014
Subjects
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor - analysis
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Disease-Free Survival
Female
Hematology, Oncology and Palliative Medicine
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Ki-67 Antigen - analysis
Ki-67 Antigen - biosynthesis
Ki67
Middle Aged
Obstetrics and Gynecology
Prognosis
Prognostic marker
Proliferation
Receptor, ErbB-2 - analysis
Receptor, ErbB-2 - biosynthesis
Receptors, Estrogen - analysis
Receptors, Estrogen - biosynthesis
Retrospective Studies
Subgroups
Proliferation
Ki67
ER
Prognostic marker
Subgroups
Online AccessGet full text

Cover

More Information
Summary:Micro-Abstract We aimed to estimate the usefulness of scoring categories of IHC Ki67 as a prognostic factor for breast cancer subgroups. Our data demonstrated that Ki67 scores have a prognostic value in breast cancer patients with ER-positive and HER2-negative tumors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1526-8209
1938-0666
DOI:10.1016/j.clbc.2013.12.013